• HPV (Human Papillomavirus)
  • Vaccine Recommendations

I have a few patients who received their first or second dose of HPV vaccine at age 26 years or younger, but did not complete the series. Should I routinely complete their series after age 26 years, or do I need to use the shared clinical decision-making approach?

Complete the series based on shared clinical decision-making involving the patient’s risk and desire for protection.

Last reviewed: March 2, 2024

This page was updated on .